Clinical · Molecular biology · Bioinfo & AI
Latent Class Analysis-Derived Classification and Cancer-Specific Death in Endometrial Carcinoma: A Population-Based Cohort Study
This study developed a novel clinical classification for endometrial carcinoma (EC) using latent class analysis (LCA) on a large cohort of 46,772 cases from the SEER program. Five clinically interpretable classes emerged, each associated with distinct risks of cancer-specific mortality (CSM) and TCGA molecular subtypes. Integrating this LCA classification into molecular survival models improved prognostic discrimination. Furthermore, class-specific transcriptomic signatures involving metabolic reprogramming, DNA repair, and immune pathways were identified. The benefits of combined treatments (surgery, radiotherapy, chemotherapy) varied significantly by class, suggesting a more personalized therapeutic approach.